Okuvision –Sehen erhalten
Our Innovation Against Progression
OkuStim® therapy for patients with retinitis pigmentosa
OkuStim® therapy: Effect & Application
OkuStim® therapy can slow the progression of visual field loss in patients with retinitis pigmentosa (RP). This can delay severe impairments due to vision loss.
OkuStim® therapy with transcorneal electrical stimulation (TES) involves the introduction of weak electrical impulses into the eye via the cornea. These impulses then spread throughout the eye, stimulating certain cells in the retina. The aim is to activate protective mechanisms in the retina that can slow down the progression of the disease and prevent or delay the onset of later stages of RP.
Clinical Trails: Design, Safety & Evaluation (G-BA)
Clinical Trials show that regular use of OkuStim® can maintain retinal activity and preserve vision longer. Furthermore, the safety of its application has been unequivocally proven. The long-term effect is currently being evaluated in a trial funded by health insurance companies. Randomized and multicenter studies are progressively strengthening the evidence base.
Experiences with OkuStim®
Anja Renner – Don't Give Up
Paratriathlete with Usher syndrom, <10% residual vision – her mantra: don’t give up, adapt step by step, stay mentally strong.
Reinhard John – Everything but Flying
Ex-pilot with RP relies on TES to stabilize his current vision status for as long as possible; training and clear routines provide structure.
Discover the Okuvision Story
Our History
Since 2007 on the path from research to care; CE mark 2014, OkuStim® 2 approval in 2025. Today, a Europe-wide network & continuous development.
Our Motivation
Preserving vision – act today: We combine scientific diligence, technical quality, and clear communication – for self-determined decisions and tangible benefits in everyday life.
Our Network
Together with PRO RETINA, Retina Suisse, and Retina International, we strengthen awareness & care; close networking with clinics and study centers.
Insights into Therapy,Research & Company
Patient Story – Anja Renner
Paratriathlete Anja Renner openly shares her life with RP and her experiences with OkuStim® therapy – honest, relatable, encouraging.
Education & Career: Achieving Disadvantage Compensation
Fair conditions without special privileges: How to apply for adjustments and implement them practically.
Interview: Founding & Vision
Alfred Stett on the journey from neurostimulation to evidence-based care—and what drives Okuvision.
Everything but Flying
Former pilot Reinhard stabilizes his condition with TES – with routine and confidence.